The global Medical Robots Market is expected to witness substantial expansion through 2028, driven by rising surgical volumes, rapid technological advancements, and increasing adoption of automation in healthcare. The market is projected to grow from US$ 9,189.70 million in 2022 to US$ 25,443.36 million by 2028, registering a strong CAGR of 18.5%. This growth outlook is reshaping competitive dynamics, with diversified healthcare leaders such as Abbott and Danaher playing a strategic role alongside specialized robotics manufacturers.

Market Outlook and Growth Fundamentals

The outlook for the medical robots market remains highly positive as healthcare systems worldwide seek solutions that improve precision, efficiency, and patient outcomes. The rising prevalence of chronic conditions such as cardiovascular diseases, cancer, diabetes, and obesity has led to a significant increase in surgical procedures. This surge in procedural volume creates strong demand for robotic systems that enable minimally invasive surgeries with reduced recovery times and lower complication risks.

Medical robots are increasingly being deployed across surgery, rehabilitation, patient monitoring, pharmacy automation, and hospital logistics. Continuous product launches, regulatory approvals, and advancements in robotic accuracy and software capabilities further strengthen the long term market outlook. Although high installation and procedural costs remain a challenge, growing hospital investments and improving cost efficiency are supporting sustained adoption.

Competitive Role of Abbott and Danaher

Abbott and Danaher hold influential positions in the broader medical robots ecosystem through their strong capabilities in diagnostics, life sciences, and healthcare automation. While neither company is solely focused on surgical robotics, their technologies support robotic assisted healthcare delivery by enhancing diagnostics, imaging, laboratory automation, and clinical workflows.

Abbott contributes to the competitive landscape through its extensive portfolio of medical devices and diagnostic solutions that complement robotic assisted procedures. Its focus on integrated healthcare technologies enables improved decision making and procedural accuracy in robotic environments. Danaher, with its leadership in life sciences tools and diagnostics, supports robotic applications by providing advanced analytical systems, imaging technologies, and automation platforms that enhance efficiency across hospitals and laboratories.

These strengths position Abbott and Danaher as important enablers within the medical robots market, reinforcing competitive intensity and innovation across the value chain.

Download Sample PDF : https://www.theinsightpartners.com/sample/TIPHE100000816

Product, Application, and End User Competitive Trends

Surgical robots continue to dominate the market in terms of revenue share, driven by their widespread use in orthopedics, cardiology, neurology, and laparoscopic procedures. Companies compete by offering systems with improved visualization, greater precision, and enhanced surgeon control. Rehabilitation robots are emerging as a high growth segment, supported by increasing demand for post operative therapy and mobility assistance.

From an application perspective, laparoscopy remains the leading segment due to the global shift toward minimally invasive procedures. Neurology is expected to register the fastest growth as robotic systems gain acceptance for complex brain and spinal surgeries. Hospitals remain the largest end users, accounting for the majority of robotic system installations, while ambulatory surgical centers are gradually expanding adoption.

Key Players in the Medical Robots Market

• Abbott

• Danaher

• Intuitive Surgical, Inc.

• Stryker Corporation

• Medtronic

• Accuray Incorporated

• Omnicell Inc.

• Hocoma AG

• Ekso Bionics Holdings, Inc.

• Auris Health, Inc.

These companies focus on innovation, partnerships, and geographic expansion to strengthen competitive positioning.

Trending Reports :

Healthcare Companion Robots Market

Nursing Robots Market

Future Outlook

Looking ahead to 2028, the medical robots market is expected to remain highly competitive and innovation driven. Integration of artificial intelligence, enhanced automation, and next generation robotic platforms will continue to redefine healthcare delivery. Abbott and Danaher are likely to strengthen their roles as technology enablers, while pure play robotics companies expand their clinical reach. Emerging markets in Asia Pacific and Latin America present significant growth opportunities, supporting the market’s projected valuation of US$ 25,443.36 million by 2028.

Questions :

1. Why are Abbott and Danaher important in the medical robots market outlook?
Abbott and Danaher support the market through diagnostics, automation, and healthcare technologies that enhance robotic assisted procedures and clinical workflows.

2. Which segment is expected to grow fastest by 2028?
Rehabilitation robots and neurology based applications are expected to witness the fastest growth due to increasing demand for precision driven treatments and post surgical recovery solutions.